Pearls of Practice Part 4: Emerging trends in Pharmacology

Pearls of Practice Part 4: Emerging trends in Pharmacology

This unique conference, dedicated to pharmacology lectures, promises record attendance due to recent changes in Advance Practice certification and required CE for pharmacology.

7:30-8:30
Registration, Breakfast & Welcome*

8:30-9:30
New Paradigm in the Management of Type 2 Diabetes
Shivani Narasimhan, MD

9:30-10:30
Beyond SSRI's: Psychiatric Pharmacology Update For Primary Care
Sabrina Sepulveda, CRNP-PMH

10:30-11:00
Break and Poster Presentation*

11:00-12:00
Antibiotic Resistance: A Threat to Modern Medicine
Valerie D. Barnes, PharmD, MS, BCPS

12:00-1:00
Lunch, Exhibits & Poster Presentation*

1:00-2:00
The Beers Criteria: Taking A Closer Look
Clarence Moore, PharmD, BCPS, BCOP2:00-3:00

Overview of Immuno-Oncology Therapy
Bob Wright, PharmD, Lucretia Jones, PharmD & Madelaine Binner, CRNP, DNP

3:00-4:00
Simplifying Pain Management: A multi-modal approach to the management of pain
Amanda Chipko, MSN RN, CRNP, FNP-BC, ACHPN

(This lecture meets the new Board of Nursing requirement for nurse prescribers on the safe prescribing of opiates, soon to be added to the Nurse Practice Act)

BONUS POSTER PRESENTATION:
The Road to Independence: Pursuit of Full Practice Authority

Representatives from MBON, The State Drug Overdose Program, and MOLST will be available for questions and comments.

Representatives from Maryland Prescription Drug Monitoring Program (PDMP) will be at the conference to help everyone register for the Chesapeake Regional Information System for our Patients, or CRISP – see below!

Beginning October 1, 2016, practitioners authorized to prescribe CDS in Maryland must be registered with the PDMP prior to obtaining a new or renewal state CDS Registration OR by July 1, 2017, whichever occurs sooner. Visit the DHMH PDMP website for updated information, important compliance dates and Frequently Asked Questions: http://bha.dhmh.maryland.gov/PDMP.

• APNs/PAs/MDs/Pharmacists $55.00
• NP/PA/MD/Pharmacy Students $25.00
• MAAPC Student Members Free!
• Students join MAAPC now for $50.00 and attend this conference for free!

MAAPC is dedicated to initiating and supporting legislation for all Advanced Practice Clinicians in Maryland and to providing affordable, local Continuing Education opportunities.

Become a member now and help keep APNs autonomous in Maryland!

This activity is approved for 6.0 contact hours of continuing education (which includes 6.0 hours pharmacology) by the American Association of Nurse Practitioners. This activity was planned in accordance with AANP Accreditation Standards and Policies.

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing MedicalEducation (ACCME) through the joint providership of Anne Arundel Medical Center and Maryland Academy of Advanced Practice Clinicians (MAAPC). The Anne Arundel Medical Center is accredited by MedChi, The Maryland State Medical Society to provide continuing medical education for physicians. The Anne Arundel Medical Center designates this educational activity for a maximum of (6) AMA PRA Category 1 Credit™. Physicians should claim only those hours of credit commensurate with the extent of their participation in the activity.

The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity (UAN: 0025-9999-16-117-L01-P) meets ACPE criteria for 6.0 contact hours (0.6 CEU) of continuing education credit. Successful completion requires documentation of attendance, participation in all sessions, and completion of an activity evaluation. No partial credit will be given. Statements of credit will be posted to CPE Monitor for all participants who successfully complete the activity within three weeks of the activity. This activity is jointly provided by the Maryland Academy of Advanced Practice Clinicians.

The faculty and planners for this activity have disclosed that they have no relationships with commercial interests that may present a conflict of interest in the discussion of the educational content within their sessions